NO20065246L - Behandling ved soppinfeksjoner - Google Patents

Behandling ved soppinfeksjoner

Info

Publication number
NO20065246L
NO20065246L NO20065246A NO20065246A NO20065246L NO 20065246 L NO20065246 L NO 20065246L NO 20065246 A NO20065246 A NO 20065246A NO 20065246 A NO20065246 A NO 20065246A NO 20065246 L NO20065246 L NO 20065246L
Authority
NO
Norway
Prior art keywords
treatment
fungal infections
antibody
composition
posaconazole
Prior art date
Application number
NO20065246A
Other languages
English (en)
Norwegian (no)
Inventor
James Peter Burnie
Ruth Christne Matthews
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of NO20065246L publication Critical patent/NO20065246L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20065246A 2004-04-23 2006-11-15 Behandling ved soppinfeksjoner NO20065246L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409077.5A GB0409077D0 (en) 2004-04-23 2004-04-23 Treatment of fungal infections
PCT/GB2005/001478 WO2005102386A1 (en) 2004-04-23 2005-04-18 Treatment of fungal infections

Publications (1)

Publication Number Publication Date
NO20065246L true NO20065246L (no) 2006-11-15

Family

ID=32344282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065246A NO20065246L (no) 2004-04-23 2006-11-15 Behandling ved soppinfeksjoner

Country Status (29)

Country Link
US (1) US7785571B2 (de)
EP (3) EP2044954A1 (de)
JP (1) JP2007533716A (de)
KR (1) KR20080024944A (de)
CN (1) CN1946424A (de)
AT (1) ATE424846T1 (de)
AU (1) AU2005235339B2 (de)
BR (1) BRPI0510052A (de)
CA (1) CA2564137A1 (de)
CY (1) CY1109121T1 (de)
DE (1) DE602005013197D1 (de)
DK (1) DK1737488T3 (de)
EC (1) ECSP067022A (de)
ES (1) ES2322171T3 (de)
GB (1) GB0409077D0 (de)
HR (1) HRP20090261T1 (de)
IL (1) IL178565A0 (de)
MA (1) MA28717B1 (de)
MX (1) MXPA06012256A (de)
NO (1) NO20065246L (de)
NZ (1) NZ550450A (de)
PL (1) PL1737488T3 (de)
PT (1) PT1737488E (de)
RU (1) RU2380116C2 (de)
SG (1) SG152269A1 (de)
SI (1) SI1737488T1 (de)
TN (1) TNSN06339A1 (de)
WO (1) WO2005102386A1 (de)
ZA (1) ZA200608767B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
EP2743699A4 (de) * 2011-08-12 2015-04-08 Nat Inst Infectious Diseases Verfahren zum testen auf, verhindern und behandeln der infektionserkrankung aspergillus fumigatus und zusammensetzung
CN111116743B (zh) * 2018-10-30 2022-01-28 迈威(上海)生物科技股份有限公司 Hsp90抗体及其在抗真菌感染中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915019D0 (en) 1989-06-30 1989-08-23 Matthews Ruth C Medicaments
RU2073512C1 (ru) * 1995-03-21 1997-02-20 Саратовская научно-исследовательская ветеринарная станция Способ лечения аспергиллеза у кроликов
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
GB0008305D0 (en) 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
RU2188019C1 (ru) * 2001-06-13 2002-08-27 Открытое акционерное общество "Биосинтез" Фармацевтическая композиция, обладающая противогрибковой активностью, и способ ее получения
MXPA05003124A (es) 2002-09-23 2005-06-22 Schering Corp Uso de posaconazol para el tratamiento de infecciones fungales.

Also Published As

Publication number Publication date
US7785571B2 (en) 2010-08-31
US20080095778A1 (en) 2008-04-24
DK1737488T3 (da) 2009-07-06
CA2564137A1 (en) 2005-11-03
HK1100320A1 (en) 2007-09-14
BRPI0510052A (pt) 2007-10-16
MXPA06012256A (es) 2007-06-15
AU2005235339B2 (en) 2010-11-25
EP1737488B1 (de) 2009-03-11
PT1737488E (pt) 2009-05-11
RU2006141354A (ru) 2008-05-27
ECSP067022A (es) 2007-02-28
EP2044954A1 (de) 2009-04-08
GB0409077D0 (en) 2004-05-26
ATE424846T1 (de) 2009-03-15
PL1737488T3 (pl) 2009-08-31
CN1946424A (zh) 2007-04-11
ZA200608767B (en) 2008-06-25
SG152269A1 (en) 2009-05-29
AU2005235339A1 (en) 2005-11-03
IL178565A0 (en) 2007-02-11
NZ550450A (en) 2009-02-28
JP2007533716A (ja) 2007-11-22
EP2039369A1 (de) 2009-03-25
SI1737488T1 (sl) 2009-08-31
WO2005102386A1 (en) 2005-11-03
RU2380116C2 (ru) 2010-01-27
ES2322171T3 (es) 2009-06-17
MA28717B1 (fr) 2007-07-02
TNSN06339A1 (en) 2008-02-22
EP1737488A1 (de) 2007-01-03
DE602005013197D1 (de) 2009-04-23
KR20080024944A (ko) 2008-03-19
CY1109121T1 (el) 2014-07-02
HRP20090261T1 (hr) 2009-07-31

Similar Documents

Publication Publication Date Title
CY1110188T1 (el) Αντισωματα κατα συζυγων φωσφορυλχολινης
WO2007022520A3 (en) Antibody-mediated enhancement of immune response
NO20074563L (no) Novel anti-plgf antibody
WO2007075525A3 (en) Combination of an iap-inhibitor and a taxane7
WO2007011941A3 (en) Human anti-b7rp1 neutralizing antibodies
HUE048404T2 (hu) Claudin-18 elleni monoklonális antitestek rák kezelésére
WO2005010048A3 (en) Rg1 antibodies and uses thereof
GB0008305D0 (en) Treatment of fungal infections
WO2002075274A3 (fr) Methode et trousse pour le suivi des maladies neurodegeneratives
WO2002057794A3 (en) Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
WO2005067956A3 (en) Use of interleukin-21 for the treatment of autoimune diseases and allograft rejection
CY1109121T1 (el) Θεραπεια μυκητιασικων μολυνσεων
WO2007019373A3 (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment
WO2006137938A3 (en) Antibody fragments for protection from pathogen infection and methods of use thereof
DE602005007485D1 (de) Medikament zur behandlung von pilzinfektionen; insbesondere aspergillose
AR055072A1 (es) Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical
WO2007002525A3 (en) Tomoregulin antibodies and uses thereof
NO20035175L (no) Anordning ved spjeld.
WO2005047309A3 (en) Prophylactic and therapeutic monoclonal antibodies
WO2006065549A3 (en) Attenuated vaccine useful for immunizations against coccidioides spp. infections
ITRM20040483A1 (it) Depolveratore per polveri di pietra arenaria o simili.
AU2004902842A0 (en) Monoclonal antibody against ABCA1
WO2007005715A3 (en) Staphylococcal antibodies which cross-react with fungal antigens

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application